Literature DB >> 23217424

MEF promotes stemness in the pathogenesis of gliomas.

Elena Bazzoli1, Teodoro Pulvirenti, Moritz C Oberstadt, Fabiana Perna, Boyoung Wee, Nikolaus Schultz, Jason T Huse, Elena I Fomchenko, Francesca Voza, Viviane Tabar, Cameron W Brennan, Lisa M DeAngelis, Stephen D Nimer, Eric C Holland, Massimo Squatrito.   

Abstract

High-grade gliomas are aggressive and uniformly fatal tumors, composed of a heterogeneous population of cells that include many with stem-cell-like properties. The acquisition of stem-like traits might contribute to glioma initiation, growth, and recurrence. Here we investigated the role of the transcription factor myeloid Elf-1 like factor (MEF, also known as ELF4) in gliomas. We found that MEF is highly expressed in both human and mouse glioblastomas and its absence impairs gliomagenesis in a PDGF-driven glioma mouse model. We show that modulation of MEF levels in both mouse neural stem cells and human glioblastoma cells has a significant impact on neurosphere formation. Moreover, we identify Sox2 as a direct downstream target of MEF. Taken together, our studies implicate MEF as a previously unrecognized gatekeeper gene in gliomagenesis that promotes stem cell characteristics through Sox2 activation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217424      PMCID: PMC3812924          DOI: 10.1016/j.stem.2012.09.012

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  30 in total

Review 1.  Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies.

Authors:  Tetyana Denysenko; Luisa Gennero; Maria Augusta Roos; Antonio Melcarne; Carola Juenemann; Giuliano Faccani; Isabella Morra; Giovanni Cavallo; Stefano Reguzzi; Gianpiero Pescarmona; Antonio Ponzetto
Journal:  Cell Biochem Funct       Date:  2010-07       Impact factor: 3.685

Review 2.  Advances in reprogramming somatic cells to induced pluripotent stem cells.

Authors:  Minal Patel; Shuying Yang
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

Review 3.  Brain tumour stem cells.

Authors:  Angelo L Vescovi; Rossella Galli; Brent A Reynolds
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

Review 4.  Sox2 roles in neural stem cells.

Authors:  Larysa H Pevny; Silvia K Nicolis
Journal:  Int J Biochem Cell Biol       Date:  2009-09-03       Impact factor: 5.085

Review 5.  The oncogenic role of the ETS transcription factors MEF and ERG.

Authors:  Goro Sashida; Elena Bazzoli; Silvia Menendez; Yan Liu; Stephen D Nimer
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

Review 6.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

7.  PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.

Authors:  Tatsuya Ozawa; Cameron W Brennan; Lu Wang; Massimo Squatrito; Takashi Sasayama; Mitsutoshi Nakada; Jason T Huse; Alicia Pedraza; Satoshi Utsuki; Yoshie Yasui; Adesh Tandon; Elena I Fomchenko; Hidehiro Oka; Ross L Levine; Kiyotaka Fujii; Marc Ladanyi; Eric C Holland
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

8.  Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain.

Authors:  Lixin Sun; Ai-Min Hui; Qin Su; Alexander Vortmeyer; Yuri Kotliarov; Sandra Pastorino; Antonino Passaniti; Jayant Menon; Jennifer Walling; Rolando Bailey; Marc Rosenblum; Tom Mikkelsen; Howard A Fine
Journal:  Cancer Cell       Date:  2006-04       Impact factor: 31.743

9.  Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.

Authors:  Rossella Galli; Elena Binda; Ugo Orfanelli; Barbara Cipelletti; Angela Gritti; Simona De Vitis; Roberta Fiocco; Chiara Foroni; Francesco Dimeco; Angelo Vescovi
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

10.  Direct conversion of fibroblasts to functional neurons by defined factors.

Authors:  Thomas Vierbuchen; Austin Ostermeier; Zhiping P Pang; Yuko Kokubu; Thomas C Südhof; Marius Wernig
Journal:  Nature       Date:  2010-01-27       Impact factor: 49.962

View more
  19 in total

Review 1.  The sox family of transcription factors: versatile regulators of stem and progenitor cell fate.

Authors:  Abby Sarkar; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2013-01-03       Impact factor: 24.633

Review 2.  The evolving landscape of glioblastoma stem cells.

Authors:  Kenneth Yan; Kailin Yang; Jeremy N Rich
Journal:  Curr Opin Neurol       Date:  2013-12       Impact factor: 5.710

3.  Tumor-derived exosomes orchestrate the microRNA-128-3p/ELF4/CDX2 axis to facilitate the growth and metastasis of gastric cancer via delivery of LINC01091.

Authors:  Qiang Wang; Chunmei Zhang; Shengya Cao; Hongying Zhao; Rongke Jiang; Yanfang Li
Journal:  Cell Biol Toxicol       Date:  2022-06-08       Impact factor: 6.691

4.  [ELF4 promotes proliferation and inhibits apoptosis of human insulinoma cells by activating Akt signaling].

Authors:  G Wei; L Wang; X Wan; Y Tan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-08-31

5.  Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells.

Authors:  Kuancan Liu; Ming Jiang; Yun Lu; Hao Chen; Jun Sun; Shaoping Wu; Wei-Yao Ku; Hiroshi Nakagawa; Yoshiaki Kita; Shoji Natsugoe; Jeffrey H Peters; Anil Rustgi; Mark W Onaitis; Amy Kiernan; Xiaoxin Chen; Jianwen Que
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

6.  The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism.

Authors:  Mary Ann Suico; Ryosuke Fukuda; Rui Miyakita; Kosuke Koyama; Manabu Taura; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Biol Chem       Date:  2014-07-31       Impact factor: 5.157

7.  The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2).

Authors:  Robyn T Sussman; Timothy J Stanek; Paul Esteso; John D Gearhart; Karen E Knudsen; Steven B McMahon
Journal:  J Biol Chem       Date:  2013-06-12       Impact factor: 5.157

Review 8.  Function of oncogenes in cancer development: a changing paradigm.

Authors:  Carolina Vicente-Dueñas; Isabel Romero-Camarero; Cesar Cobaleda; Isidro Sánchez-García
Journal:  EMBO J       Date:  2013-04-30       Impact factor: 11.598

9.  ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State.

Authors:  Adam Kosti; Liqin Du; Haridha Shivram; Mei Qiao; Suzanne Burns; Juan Gabriel Garcia; Alexander Pertsemlidis; Vishwanath R Iyer; Erzsebet Kokovay; Luiz O F Penalva
Journal:  Mol Cancer Res       Date:  2019-10-17       Impact factor: 5.852

10.  Long Noncoding RNA PVT1 Promotes Stemness and Temozolomide Resistance through miR-365/ELF4/SOX2 Axis in Glioma.

Authors:  Rui Gong; Zhi-Qiang Li; Kai Fu; Chao Ma; Wei Wang; Jin-Cao Chen
Journal:  Exp Neurobiol       Date:  2021-06-30       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.